Wednesday, July 8, 2026

biotech · Breast Cancer · Sarcoma,Soft Tissue · INTS

INTENSITY THERAPEUTICS

INTENSITY THERAPEUTICS trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.

Shelton, USA HQ
2012 Founded
12 Employees
Public company Type
INTS · NYSE Ticker
Company details
Status
Public
HQ
Shelton, USA
Founded
2012
Employees
12
Programs
6
Drugs
9
Patents
3
Intelligence · Clinical Trials

INTENSITY THERAPEUTICS clinical trials

Registry index of 7 ClinicalTrials.gov studies linked to INTENSITY THERAPEUTICS programs — each row shows trial ID, program name, phase, status, and indication.

INTENSITY THERAPEUTICS trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

6 updates

Latest clinical program signals indexed for INTENSITY THERAPEUTICS.

  1. IT-03 — Phase 3

    Clinical update
  2. INT230-6 — Phase 3

    Clinical update
  3. INT230-6 — Phase 2

    Clinical update
  4. JIN-A02 — Phase 2

    Clinical update
  5. MPT0B640 — Phase 1

    Clinical update
  6. MPT0B640 — Phase 1

    Clinical update

Trial registry

7 studies
  1. 2024-512423-36-00

    IT-03

    Phase 3 active small_molecule

    liposarcoma (dedifferentiated, myxoid, round cell or pleomorphic), Leiomyosarcoma (non-uterine), Undifferentiated pleomorphic sarcoma

    CTIS ↗